MoneyWorks4Me

Ind-Swift Laboratories informs about outcome of board meeting

17 Jan 2019 Evaluate

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Ind-Swift Laboratories has informed that Board of Directors in its meeting held on 16th January, 2019 have approved to convene Extra Ordinary General Meeting of the members of the company on 11th February, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..